Efficacy of Continuous Real-Time Blood Glucose Monitoring During and After Prolonged High-Intensity Cycling Exercise: Spinning with a Continuous Glucose Monitoring System

2006 ◽  
Vol 8 (6) ◽  
pp. 627-635 ◽  
Author(s):  
Katherine E. Iscoe ◽  
Jonathan E. Campbell ◽  
Veronica Jamnik ◽  
Bruce A. Perkins ◽  
Michael C. Riddell
Keyword(s):  
Blood Glucose ◽  
Real Time ◽  
Monitoring System ◽  
Continuous Glucose Monitoring ◽  
High Intensity ◽  
Glucose Monitoring ◽  
Blood Glucose Monitoring ◽  
Continuous Glucose Monitoring System ◽  
Cycling Exercise

scholarly journals Accuracy of a real-time continuous glucose monitoring system in children with septic shock: A pilot study

2015 ◽  
Vol 19 (11) ◽  
pp. 642-647 ◽  
Author(s):  
Bala Ramachandran ◽  
Amruta Kanjani ◽  
Sumant Prabhudesai ◽  
Isha Bhagat ◽  
Karnam G. Ravikumar
Keyword(s):  
Septic Shock ◽  
Pilot Study ◽  
Real Time ◽  
Monitoring System ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Continuous Glucose Monitoring System

Performance of a factory‐calibrated, real‐time continuous glucose monitoring system during elective abdominal surgery

2020 ◽  
Vol 22 (9) ◽  
pp. 1678-1682 ◽  
Author(s):  
Afroditi Tripyla ◽  
David Herzig ◽  
Dehais Joachim ◽  
Christos T. Nakas ◽  
Franziska Amiet ◽  
...  
Keyword(s):  
Abdominal Surgery ◽  
Real Time ◽  
Monitoring System ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Continuous Glucose Monitoring System ◽  
Elective Abdominal Surgery

scholarly journals Pre- and Postoperative Accuracy and Safety of a Real-Time Continuous Glucose Monitoring System in Cardiac Surgical Patients: A Randomized Pilot Study

2009 ◽  
Vol 11 (1) ◽  
pp. 31-37 ◽  
Author(s):  
Susan J. Logtenberg ◽  
Nanne Kleefstra ◽  
Ferdinand T. Snellen ◽  
Klaas H. Groenier ◽  
Robbert J. Slingerland ◽  
...  
Keyword(s):  
Pilot Study ◽  
Real Time ◽  
Monitoring System ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Surgical Patients ◽  
Continuous Glucose Monitoring System

Healthcare Utilization, Costs, and Adverse Events of Real-Time Continuous Glucose Monitoring (rtCGM) versus Traditional Blood Glucose Monitoring (BG) among US Adults with Type 1 Diabetes

2021 ◽  
pp. 193229682110315
Author(s):  
Benjamin Wong ◽  
Yalin Deng ◽  
Karen L. Rascati
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Adverse Events ◽  
Real Time ◽  
Healthcare Utilization ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Medical Costs ◽  
Blood Glucose Monitoring

Objective: To compare healthcare utilization, costs, and incidence of diabetes-specific adverse events (ie, hyperglycemia, diabetic ketoacidosis, and hypoglycemia) in type 1 diabetes adult patients using real-time continuous glucose monitoring (rtCGM) versus traditional blood glucose monitoring (BG). Methods: Adult patients (≥18 years old) with type 1 diabetes in a large national administrative claims database between 2013 and 2015 were identified. rtCGM patients with 6-month continuous health plan enrollment and ≥1 pharmacy claim for insulin during pre-index and post-index periods were propensity-score matched with BG patients. Healthcare utilization associated with diabetic adverse events were examined. A difference-in-difference (DID) method was used to compare the change in costs between rtCGM and BG cohorts. Results: Six-month medical costs for rtCGM patients ( N = 153) increased from pre- to post-index period, while they decreased for matched BG patients ( N = 153). DID analysis indicated a $2,807 ( P = .062) higher post-index difference in total medical costs for rtCGM patients. Pharmacy costs for both cohorts increased. DID analysis indicated a $1,775 ( P < .001) higher post-index difference in pharmacy costs for rtCGM patients. The incidence of hyperglycemia for both cohorts increased minimally from pre- to post-index period. The incidence of hypoglycemia for rtCGM patients decreased, while it increased marginally for BG patients. Inpatient hospitalizations for rtCGM and BG patients increased and decreased marginally, respectively. Conclusions: rtCGM users had non-significantly higher pre-post differences in medical costs but significantly higher pre-post differences in pharmacy costs (mostly due to the rtCGM costs themselves) compared to BG users. Changes in adverse events were minimal.

Sign in / Sign up

Export Citation Format

Share Document